Fig. 2From: Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CTComparison of hepatic 18F-FDG uptake (a), CT density (b) and the ratio of spleen/liver CT densities (c) between non-NAFLD patients with normal liver function and non-NAFLD patients with abnormal liver function. Patients with ALT≥50 u/L was considered to have abnormal liver functionBack to article page